EUVIMEDEUVIMED entdecken
Open Access

IFNL4 Genotypes and Risk of Childhood Burkitt Lymphoma in East Africa

Francine S Baker iD, Jeanny Wang, Oscar Florez-Vargas, Nathan R Brand, Martin D Ogwang, Patrick Kerchan, Steven J Reynolds, Constance N Tenge, Pamela A Were, Robert T Kuremu, Walter N Wekesa, Nestory Masalu und 16 weitere

Journal of Interferon & Cytokine Research · 2023

DOI: 10.1089/jir.2023.0014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Interferon & Cytokine Research, 2023. Verfasst von Francine S Baker und 27 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Translational Genomics, National Cancer Institute, Rockville, Maryland, USA. Hauptthemen laut MEDLINE: Burkitt Lymphoma, Hepatitis C. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Council, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interferon lambda 4 (IFN-λ4) is a novel type-III interferon that can be expressed only by carriers of the genetic variant rs368234815-dG within the first exon of the IFNL4 gene. Genetic inability to produce IFN-λ4 (in carriers of the rs368234815-TT/TT genotype) has been associated with improved clearance of hepatitis C virus (HCV) infection. The IFN-λ4-expressing rs368234815-dG allele ( IFNL4 -dG) is most common (up to 78%) in West sub-Saharan Africa (SSA), compared to 35% of Europeans and 5% of individuals from East Asia. The negative selection of IFNL4 -dG outside Africa suggests that its retention in African populations could provide survival benefits, most likely in children. To explore this hypothesis, we conducted a comprehensive association analysis between IFNL4 genotypes and the risk of childhood Burkitt lymphoma (BL), a lethal infection-associated cancer most common in SSA. We used genetic, epidemiologic, and clinical data for 4,038 children from the Epidemiology of Burkitt Lymphoma in East African Children and Minors (EMBLEM) and the Malawi Infections and Childhood Cancer case–control studies. Generalized linear mixed models fit with the logit link controlling for age, sex, country, P. falciparum infection status, population stratification, and relatedness found no significant association between BL risk and 3 coding genetic variants within IFNL4 (rs368234815, rs117648444, and rs142981501) and their combinations. Because BL occurs in children 6–9 years of age who survived early childhood infections, our results suggest that additional studies should explore the associations of IFNL4 -dG allele in younger children. This comprehensive study represents an important baseline in defining the health effects of IFN-λ4 in African populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Burkitt LymphomaHepatitis CChild, PreschoolChildHumansGenotypeHepacivirusAfrica, EasternInterleukinsPolymorphism, Single NucleotideInterferon Lambda

Stichwörter der Autor:innen

Burkitt LymphomaIFNL4genetic susceptibilityinfectioninterferon Lambda 4

Substanzen

InterleukinsIFNL4 protein, humanInterferon Lambda

Autor:innen und Institutionen

  • Laboratory of Translational Genomics, National Cancer Institute, Rockville, Maryland, USA.
  • Department of Surgery, University of California, San Francisco, California, USA.
  • EMBLEM Study, St. Mary's Hospital, Lacor, Uganda.
  • EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.
  • EMBLEM Study, Kuluva Hospital, Arua, Uganda.
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

ORCID-Profile: Francine S Baker, Ludmila Prokunina-Olsson, Sam M Mbulaiteye

Förderung

  • Medical Research Council
  • NCI NIH HHS

Zitieren

APA

Baker, F. S., Wang, J., Florez-Vargas, O., Brand, N. R., Ogwang, M. D., Kerchan, P., Reynolds, S. J., Tenge, C. N., Were, P. A., Kuremu, R. T., Wekesa, W. N., Masalu, N., Kawira, E., Kinyera, T., Otim, I., Legason, I. D., Nabalende, H., Chagaluka, G., Mutalima, N., …, & Mbulaiteye, S. M. (2023). IFNL4 Genotypes and Risk of Childhood Burkitt Lymphoma in East Africa. Journal of Interferon & Cytokine Research. https://doi.org/10.1089/jir.2023.0014

Vancouver

Baker FS, Wang J, Florez-Vargas O, Brand NR, Ogwang MD, Kerchan P, et al. IFNL4 Genotypes and Risk of Childhood Burkitt Lymphoma in East Africa. Journal of Interferon & Cytokine Research. 2023. doi:10.1089/jir.2023.0014

BibTeX
@article{Baker2023,
  author = {Baker, Francine S and Wang, Jeanny and Florez-Vargas, Oscar and Brand, Nathan R and Ogwang, Martin D and Kerchan, Patrick and Reynolds, Steven J and Tenge, Constance N and Were, Pamela A and Kuremu, Robert T and Wekesa, Walter N and Masalu, Nestory and Kawira, Esther and Kinyera, Tobias and Otim, Isaac and Legason, Ismail D and Nabalende, Hadijah and Chagaluka, George and Mutalima, Nora and Borgstein, Eric and Liomba, George N and Kamiza, Steve and Mkandawire, Nyengo and Mitambo, Collins and Molyneux, Elizabeth M and Newton, Robert and Prokunina-Olsson, Ludmila and Mbulaiteye, Sam M},
  title = {IFNL4 Genotypes and Risk of Childhood Burkitt Lymphoma in East Africa},
  journal = {Journal of Interferon & Cytokine Research},
  year = {2023},
  doi = {10.1089/jir.2023.0014}
}
Kostenlos starten →